So, if you and your clinician agree that youre ready for a higher dose, it could lead to greater weight-loss benefits
While hypothesised to improve hepatocyte mitochondrial function and turnover, decrease mitochondrial oxidative stress, and decrease stellate cell activation, the anti-inflammatory and anti-fibrotic benefits of glucagon receptor agonism are more likely a consequence of overall reduction in hepatic steatosis [28, 75]
Research shows that co-activation of GLP-1 and GIP produces synergistic effects on insulin response, with combined stimulation generating significantly greater insulin secretion and glucagonostatic response compared to either hormone alone
Lower doses may have different cardiovascular effects than higher ones, and individual factors like baseline sympathetic tone, existing medications, and metabolic health influence the outcome
However, some studies suggest starting with a 1mg test dose and injecting an identical amount 30 minutes later